Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARDMQ
Aradigm
$0.05
$0.05
$0.02
$0.20
$764KN/A21,923 shsN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$4.15
-3.6%
$4.15
$2.43
$16.08
$2.54M2.03648,393 shs46,166 shs
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$0.15
-9.2%
$0.12
$0.06
$6.80
$3.06M0.46617,457 shs123,904 shs
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$0.26
-7.1%
$0.33
$0.24
$8.40
$2.30M-0.341.05 million shs150,853 shs
10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARDMQ
Aradigm
0.00%0.00%0.00%0.00%0.00%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-1.31%-1.31%-9.41%+5.47%-75.89%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-9.09%+39.13%+33.33%-23.81%-95.06%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
+2.30%-0.07%-6.70%-27.51%-95.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.0399 of 5 stars
0.02.00.00.00.60.00.0
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/AN/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.4701 of 5 stars
0.03.00.00.00.80.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARDMQ
Aradigm
0.00
N/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.00
N/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
2.00
Hold$5.003,341.16% Upside
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARDMQ
Aradigm
N/AN/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$780K3.26N/AN/A$2.44 per share1.70
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
$7.68M0.40N/AN/A($6.91) per share-0.02
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$440K5.22N/AN/A$30.16 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARDMQ
Aradigm
N/AN/A0.00N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$8.24MN/A0.00N/A-670.95%-201.30%-154.54%5/21/2025 (Estimated)
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
-$50.08MN/A0.00N/A-563.16%N/A-174.06%5/8/2025 (Estimated)
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-$70.57MN/A0.00N/AN/A-2,928.32%-69.90%-41.82%N/A

Latest ARDMQ, TTOO, TIVC, and VTAK Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2025Q4 2024
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$85.00-$19.68+$65.32N/A$1.43 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARDMQ
Aradigm
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/AN/AN/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARDMQ
Aradigm
N/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
5.65
4.34
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
N/A
0.40
0.24
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.12
0.66
0.65

Institutional Ownership

CompanyInstitutional Ownership
ARDMQ
Aradigm
N/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
23.18%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
20.34%

Insider Ownership

CompanyInsider Ownership
ARDMQ
Aradigm
4.50%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.31%
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
0.03%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
1.35%
CompanyEmployeesShares OutstandingFree FloatOptionable
ARDMQ
Aradigm
2315.28 millionN/ANot Optionable
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
10613,0009.44 millionNot Optionable
T2 Biosystems, Inc. stock logo
TTOO
T2 Biosystems
18021.04 million21.04 millionOptionable
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
148.84 million8.72 millionN/A

Recent News About These Companies

Catheter Precision to attend, participate in ISLAA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aradigm OTCMKTS:ARDMQ

$0.05 0.00 (0.00%)
As of 06/30/2020

Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung.

Tivic Health Systems stock logo

Tivic Health Systems NASDAQ:TIVC

$4.14 -0.16 (-3.60%)
Closing price 03:56 PM Eastern
Extended Trading
$4.05 -0.09 (-2.27%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

T2 Biosystems stock logo

T2 Biosystems NASDAQ:TTOO

$0.15 -0.01 (-9.19%)
As of 03:55 PM Eastern

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Catheter Precision stock logo

Catheter Precision NYSEAMERICAN:VTAK

$0.26 -0.02 (-7.08%)
Closing price 04:10 PM Eastern
Extended Trading
$0.28 +0.02 (+6.92%)
As of 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.